The selected SNPs had minor allele frequencies that were >5% (Table 1). which were located in one haplotype block. == Conclusion == TLR4 polymorphisms do not play an important role in the development of uveitis in Japanese patients with sarcoidosis. == Introduction == Sarcoidosis is a systemic inflammatory syndrome of unknown etiology characterized by the accumulation of immune effector cells in affected organs, such as lungs, lymph nodes, eyes, skin, and heart. The severity and mode of presentation are influenced by ethnicity. For instance, Lfgrens syndrome, an acute form of sarcoidosis, is more common among Caucasians, and a more serious form of sarcoidosis has been observed in patients of African descent [1,2]. The incidence of ocular involvement is higher in Japan (50-93.5%) compared to that of other countries (25-60%) [2-8]. Clinically, ocular manifestations in sarcoidosis are considered bilateral, chronic, granulomatous uveitis [9]. The variety of clinical manifestations of sarcoidosis and the observed dependence on race and familial clustering suggest there may be a genetic predisposition for developing sarcoidosis [10-12]. Numerous studies have reported genetic associations between various major histocompatibility complex (MHC) genes and the susceptibility, severity, and presentation of sarcoidosis [13-17]. The first genome-wide search for genes that predispose for sarcoidosis in German families used microsatellite linkage analysis. These studies identified several chromosomal regions that contributed to the risk of sarcoidosis. The MHC genes displayed the most prominent signal in these regions. This supported the hypothesis that MHC genes were associated with the different manifestations of sarcoidosis [18]. Furthermore, another genome-wide association study that included >440,000 single-nucleotide polymorphisms (SNPs) in patients with sarcoidosis also reported a series of genetic associations [19]. It has been suggested that sarcoidosis results from exposure of genetically susceptible hosts to specific, but unidentified environmental agents [20]. The granuloma in sarcoidosis develops, in general, as a Prostaglandin E2 response to a persistent, weakly virulent antigen(s) that induces a local helper T cell type 1 (Th1) immune response [21]. Toll-like receptors (TLRs) are transmembrane proteins that function as pattern-recognition receptors (PRRs) in innate immunity. TLRs also provide a link to the activation of adaptive immunity by recognizing microbial components and inducing the production of cytokines, such as Interleukin 12 (IL12) and IL18 driving nave T cells to differentiate into Th1 cells [22]. Among TLR family members, TLR4 is expressed in a wide variety of human cells, where it plays an important role in innate and adaptive immune responses to Gram-negative bacterial products, including lipopolysaccharides [22,23]. In recent studies,TLR4polymorphisms have been reported to be associated with various inflammatory diseases, including atherosclerosis, Crohns disease, ulcerative colitis, rheumatoid arthritis, prostate cancer, and Alzheimers disease [23-28]. These findings suggest that genetic variants of TLR4 that have abnormal ligand recognition properties may contribute to the development of various diseases, including sarcoidosis. Due to its various clinical manifestations, sarcoidosis is often considered to be a family of disorders with clinically and genetically different phenotypes, rather than a single entity [29]. This study investigated whetherTLR4polymorphisms were associated with susceptibility to sarcoidosis-related uveitis in Japanese patients. == Methods == == Subjects == Narg1 This study included 223 Japanese patients with sarcoidosis (52 men and 171 women) and 206 healthy Japanese controls (48 men and 158 women) from Yokohama City University, Hokkaido University, Fujita Health University, Tokyo University, Keio University, the Kumamoto City hospital, and the Yuasa Eye Clinic. All 223 patients had chronic sarcoidosis; 68 cases were clinically diagnosed and 155 cases were confirmed by biopsies. Prostaglandin E2 These 223 patients were divided into two groups: 196 (87.9%) with uveitis (the sarcoid-uveitis group) and 27 (12.1%) without uveitis (the sarcoid Prostaglandin E2 non-uveitis group). Clinical sarcoidosis was diagnosed according to the diagnostic criteria developed by the Japanese Society of Sarcoidosis and Other Granulomatous Disorders (JSSOG) in 1977 [9]. Uveitis with sarcoidosis was assessed based onthe Guidelines for Diagnosis of Ocular Lesions in Sarcoidosisprepared by the JSSOG. The ocular features of sarcoidosis were defined as granulomatous uveitis plus two or more of the following: infiltration of the anterior chamber (mutton-fat keratic precipitates/iris nodules), trabecular.
